Clinical Trials Browser

Phase 3 × Smoldering Multiple Myeloma × Dexamethasone × Clear all

NCT03937635 2026-03-02

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Phase 3 Recruiting

Smoldering Multiple Myeloma

NCT00480363 2013-07-31

QUIREDEX

Phase 3 Completed

Smoldering Multiple Myeloma, Multiple Myeloma